default author photo

Ghassan K. Abou-Alfa

Memorial Sloan Kettering Cancer Center - Department of Medicine

New York, NY 10065

United States

SCHOLARLY PAPERS

2

DOWNLOADS

483

TOTAL CITATIONS

4

Scholarly Papers (2)

1.

Genome-Scale Profiling of Circulating Cell-Free DNA Signatures for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

Number of pages: 55 Posted: 09 Apr 2020
National Center for Liver Cancer, Memorial Sloan Kettering Cancer Center - Department of Medicine, National Center for Liver Cancer, Fujian Medical University - United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Berry Oncology Corporation, Shandong University - Second Hospital, Chinese Academy of Sciences (CAS), Southern Medical University - Department of Infectious Diseases, Fujian Medical University - United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Xinjiang Medical University, Yangzhou University, Third Military Medical University, Southwest Hospital, Department of Infectious Diseases, Xuzhou Infectious Diseases Hospital, Fudan University, Naval Medical University (SMMU), Shanghai Eastern Hepatobiliary Surgery Hospital, Berry Oncology Corporation, Government of the People's Republic of China - First People's Hospital of Foshan, Berry Oncology Corporation, Jilin University (JLU) - First Affiliated Hospital, Third Military Medical University, Southwest Hospital, Department of Infectious Diseases, Chinese Academy of Sciences (CAS), Government of the People's Republic of China - First People's Hospital of Foshan, Inner Mongolia Medical University, Berry Oncology Corporation, Xuzhou Infectious Diseases Hospital, Southern Medical University, Shandong University - Department of Clinical Laboratory, Berry Oncology Corporation, Shanghai Eastern Hepatobiliary Surgery Hospital, Jilin University (JLU) - First Affiliated Hospital, Inner Mongolia Medical University, Xinjiang Medical University, Huazhong University of Science and Technology, Government of the People's Republic of China - Eastern Hepatobiliary Surgery Hospital, Shandong University - Department of Clinical Laboratory, Berry Oncology Corporation, Southern Medical University - State Key Laboratory of Organ Failure Research and Government of the People's Republic of China - International Cooperation Laboratory on Signal Transduction
Downloads 339 (220,543)
Citation 4

Abstract:

Loading...

cfDNA; early detection; Hepatocellular carcinoma; Cirrhosis

2.

Randomised Phase 3 Study of Ivosidenib in IDH1-Mutant Chemotherapy-Refractory Cholangiocarcinoma

Number of pages: 261 Posted: 08 Dec 2019
Memorial Sloan Kettering Cancer Center - Department of Medicine, Hospital Vall d’Hebron, University of Texas at Houston - MD Anderson Cancer Center, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of Wisconsin-Madison - Carbone Cancer Center, Hospital Universitario 12 de Octubre - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute, University of Chicago - Pritzker School of Medicine, Mayo Clinic Hospital - Phoenix, University College London - UCL Cancer Institute, University of Washington - Department of Medicine, Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center, Seoul National University - Department of Internal Medicine, Utah Cancer Specialists, Trinity College (Dublin), Harvard University - Department of Medicine, University of Arizona - Department of Medicine, University of Southern California - Norris Comprehensive Cancer Center, Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., The Christie NHS Foundation Trust - Department of Medical Oncology and Harvard University - Cancer Center
Downloads 144 (511,933)

Abstract:

Loading...

Cholangiocarcinoma; IDH1 mutation; Ivosidenib; Phase 3 study